RecruitingNot ApplicableNCT05297136

Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy

Preoperative Endoscopic Pancreatic Stent to Prevent Pancreatic Fistula After Distal Pancreatectomy: a Randomized Controlled Trial


Sponsor

Chinese University of Hong Kong

Enrollment

56 participants

Start Date

Mar 21, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Distal pancreatectomy (DP) with or without splenectomy is commonly indicated for pancreatic body or tail lesions. Postoperative pancreatic fistula (POPF) remains the commonest complication after DP. A pre-operatively placed pancreatic stent across papilla can decrease the pressure gradient between pancreatic duct and duodenum. Therefore, the pancreatic juice flow is redirected from the pancreatic transection plane and leakage from pancreatic stump is much reduced. This study aims to evaluate whether pre-operatively placed pancreatic stent can prevent POPF by a randomized controlled trial.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Age >18 years
  • Elective distal pancreatectomy for primary pancreatic pathology

Exclusion Criteria5

  • Informed consent not available
  • Emergency distal pancreatectomy
  • Presence of pancreatic duct stricture
  • Presence of altered anatomy that precludes safe Endoscopic Retrograde Cholangiography (e.g. previous Billroth II gastrectomy)
  • History of severe pancreatitis

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPancreatic Stenting

Pancreatic stent of appropriate size and length is inserted to the pancreatic duct before distal pancreatectomy

PROCEDURENo Stent

No preoperative stenting with distal pancreatectomy alone


Locations(1)

Prince of Wales Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05297136


Related Trials